Open AccessClinical and economic evaluation of the use of biologic disease-modifying antirheumatic drugs and targeted synthetic antirheumatic drugs for ankylosing spondylitis in context of the Russian healthcare system
Author(s) -
O. Ivakhnenko,
Т. В. Дубинина,
Т. В. Коротаева,
А. М. Лила
Publication year - 2022
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2022-4-46-56
Subject(s) - medicine , certolizumab pegol , tofacitinib , adalimumab , basdai , context (archaeology) , golimumab , ankylosing spondylitis , clinical trial , etanercept , physical therapy , psoriatic arthritis , rheumatoid arthritis , paleontology , biology